Gilead Sciences is a biopharmaceutical company best known for its antiviral franchises. It dominates HIV treatment and prevention with Biktarvy, the world's leading HIV regimen, and Descovy, and launched lenacapavir (Yeztugo), a twice-yearly injectable for HIV prevention regarded as a breakthrough in the field. Its liver disease portfolio spans hepatitis B and C cures and Livdelzi for primary biliary cholangitis, while Veklury (remdesivir) treats COVID-19. Oncology has become a growth pillar through cell therapies Yescarta and Tecartus from Kite Pharma and the breast cancer antibody-drug conjugate Trodelvy. Gilead licenses its medicines for low-cost generic distribution in developing countries through voluntary licensing programs. Founded in 1987, the company is headquartered in Foster City, California.

Beneish M-Score

Altman Z-Score

Insider Sell

Gilead Sciences Inc